Recombinant Diagnostics LLC filed a Form D with the Securities and Exchange Commission on 2026-06-30.
Recombinant Diagnostics LLC filed a Form D notice of an exempt securities offering with the SEC on June 30, 2026. The filing reports $150K sold. Its industry group is Other Health Care. It names William Tanenbaum (Manager of the Managing Member, Recombinant MGMT LLC) (SEC Form D, June 30, 2026).
125 companies raised this week.
Companies that just raised money, and the people to call. Before you unlock: the company, the amount, the date and what is inside (for example 2 people, phone, LinkedIn). After: the officers and directors the filing names with their roles, how to reach the company, and a person's email only when we found one.
| Andersen Aggregator LLC | $1.9B | Business services |
| AT Umbrella LLC | $1.9B | Business services |
| Legora, Inc. | $221M | AI and software |
| MD INVESTMENT LLC | $169M | Business services |
| Serval Inc. | $149M | AI and software |
Is this your company?
Sell to companies like Recombinant Diagnostics LLC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-06-30 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Recombinant Diagnostics LLC.
Free to see. No signup.
More on the people and the money behind Recombinant Diagnostics LLC, from the filings we hold.
Other Health Care raises by companies based in Florida, filed in June 2026, largest first.
Get an email when Recombinant Diagnostics LLC files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Recombinant Diagnostics LLC raises, hires or launches. No email unless you switch it on.
Watch Recombinant Diagnostics LLC →Get the full cited report on Recombinant Diagnostics LLC
What the filing shows about Recombinant Diagnostics LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Recombinant Diagnostics LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
The filing gives Recombinant Diagnostics LLC's address as 19505 Biscayne Blvd, Suite 2350, Aventura, FL 33180.
Saved here on this device in the meantime, so nothing is lost either way.
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Order the Full Report on Recombinant Diagnostics LLC See pricing
Recombinant Diagnostics LLC is a registered filer with the SEC (CIK 2141501) and has filed since 2026-06-30. 1 filing is on record, the latest on 2026-06-30.
A filing shows the company exists and what it reports about itself. It is not an audit or a rating.
Recombinant Diagnostics LLC's Form D of 2026-06-30 names William Tanenbaum and Recombinant Mgmt LLC as its officers, directors or promoters.
Its new offerings report $150K sold across 1 offering, as its own filings state.
Trailing twelve months. 866 filings in Other Health Care, totalled by week. The dot is this raise, $150K, on the same scale — one filing against the whole group's total, so it sits low by construction.
On the filing as: Executive Officer.
William Tanenbaum is named as Manager of the Managing Member, Recombinant Mgmt Llc on the Form D that Recombinant Diagnostics LLC filed with the SEC on 30 June 2026, the only person that filing names.
1 person named on the filing — 1 holding an executive role.
Named as of the 2026-06-30 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
| Entity | Stated role | Relationship on the filing | Where |
|---|---|---|---|
| Recombinant MGMT LLC | Managing Member | Executive Officer | AVENTURA, FLORIDA |
What the filing shows about Recombinant Diagnostics LLC
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Recombinant Diagnostics LLC: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Recombinant Diagnostics LLC covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
These are companies, not individuals — the filing gives them no forename, or names them as a firm. They are listed apart so a firm is never read as a person.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Recombinant Diagnostics LLCYou get an alert in MentionFox the next time this company shows up.
If you're behind Recombinant Diagnostics LLC: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for Recombinant Diagnostics LLC. With no account yet, you sign up free and land on the result.
On these lists: Health care raises in Miami
Share your raise. This card is drawn from the company's own Form D filing, and sharing needs no account.
https://mentionfox.com/funding/recombinant-diagnostics-llc-form-d-26000001